Citations (53)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Clairissa A Hansen, J Erin Staples & Alan DT Barrett. (2023) Fractional Dosing of Yellow Fever Live Attenuated 17D Vaccine: A Perspective. Infection and Drug Resistance 16, pages 7141-7154.
Read now
Read now
Gerardo Montalvo Zurbia-Flores, Christine S Rollier & Arturo Reyes-Sandoval. (2022) Re-thinking yellow fever vaccines: fighting old foes with new generation vaccines. Human Vaccines & Immunotherapeutics 18:1.
Read now
Read now
Usa Thisyakorn & Terapong Tantawichien. (2020) Dengue vaccine: a key for prevention. Expert Review of Vaccines 19:6, pages 499-506.
Read now
Read now
Stewart Sell. (2019) How vaccines work: immune effector mechanisms and designer vaccines. Expert Review of Vaccines 18:10, pages 993-1015.
Read now
Read now
Ian J. Amanna & Mark K. Slifka. (2016) Questions regarding the safety and duration of immunity following live yellow fever vaccination. Expert Review of Vaccines 15:12, pages 1519-1533.
Read now
Read now
Articles from other publishers (48)
Parikshit Tyagi, Milan Ganguly, Satyaprasad Manney, Kuntinath Wadkar, Nilesh Ingle, Sunil Gairola, Rajeev Dhere, Fusataka Koide & Sheila Grimes. (2023) Neurovirulence, viscerotropism and immunogenicity of live attenuated yellow fever 17D vaccine virus in non-human primates. Vaccine 41:3, pages 836-843.
Crossref
Crossref
Ana Carolina dos Reis Albuquerque Cajaraville, Mariana Pierre de Barros Gomes, Tamiris Azamor, Renata Carvalho Pereira, Patrícia Cristina da Costa Neves, Paula Mello De Luca, Sheila Maria Barbosa de Lima, Luciane Pinto Gaspar, Elena Caride, Marcos da Silva Freire & Marco Alberto Medeiros. (2022) Evaluation of Two Adjuvant Formulations for an Inactivated Yellow Fever 17DD Vaccine Candidate in Mice. Vaccines 11:1, pages 73.
Crossref
Crossref
Hong-Jiang Wang, Yan Guo, Meng-Jiao He, Zhong-Yu Liu, Qing Ye, Xing-Yao Huang, Yong-Qiang Deng, Xiao-Feng Li & Cheng-Feng Qin. (2022) Development of a Bicistronic Yellow Fever Live Attenuated Vaccine with Reduced Neurovirulence and Viscerotropism. Microbiology Spectrum 10:5.
Crossref
Crossref
Izabela Mauricio de Rezende, Adriana Regina Campolina Cenachi, Thais Alkifeles Costa, Gabriela Fernanda Garcia Oliveira, Livia Rabelo, Leticia Mattos Menezes, Indiara Penido, Leonardo Soares Pereira, Matheus Soares Arruda, Andreza Parreiras Gonçalves, Pedro Augusto Alves, Erna Geessien Kroon, Carlos Eduardo Calzavara-Silva, Dario Brock Ramalho, Olindo Assis Martins-Filho, Andrea Teixeira-Carvalho, A. Desiree LaBeaud & Betânia Paiva Drumond. (2022) Wild-type Yellow fever virus in cerebrospinal fluid from fatal cases in Brazil, 2018. Frontiers in Virology 2.
Crossref
Crossref
Raphael Esson, Emanuel Rodrigues De Sousa, Loic Benair, Nicolas Devard, Damien Soulet, Audrey Gillet, Isabelle Bassard, Stephanie Falque, Audrey Chareyre, Morgane Marmin, Yves Girerd-Chambaz, Carine Logvinoff & Martha Erika Navarro Sanchez. (2022) Phenotypic and genetic characterization of a next generation live-attenuated yellow fever vaccine candidate. Vaccine 40:38, pages 5641-5650.
Crossref
Crossref
Danielle Thompson, Ben Guenther, Darly Manayani, Jason Mendy, Jonathan Smith, Diego A. Espinosa, Eva Harris, Jeff Alexander, Lo Vang & Christopher S. Morello. (2022) Zika virus-like particle vaccine fusion loop mutation increases production yield but fails to protect AG129 mice against Zika virus challenge. PLOS Neglected Tropical Diseases 16:7, pages e0010588.
Crossref
Crossref
Naoaki Shinzawa, Chisako Kashima, Hiroka Aonuma, Kei Takahashi, Masayuki Shimojima, Shinya Fukumoto, Erisha Saiki, Daisuke S. Yamamoto, Shigeto Yoshida, Hiroyuki Matsuoka, Yoshihiro Kawaoka & Hirotaka Kanuka. (2022) Generation of Transgenic Mosquitoes Harboring a Replication-Restricted Virus. Frontiers in Tropical Diseases 3.
Crossref
Crossref
Emily H. Davis, Binbin Wang, Mellodee White, Yan-Jang S. Huang, Vanessa V. Sarathy, Tian Wang, Nigel Bourne, Stephen Higgs & Alan D. T. Barrett. (2022) Impact of yellow fever virus envelope protein on wild-type and vaccine epitopes and tissue tropism. npj Vaccines 7:1.
Crossref
Crossref
Joseph L. Servadio, Claudia Muñoz-Zanzi & Matteo Convertino. (2022) Environmental determinants predicting population vulnerability to high yellow fever incidence. Royal Society Open Science 9:3.
Crossref
Crossref
Dana M. Blyth, Zhaodong Liang, Maya Williams & Clinton K. Murray. (2022) Immune interference revisited: Impact of live-attenuated influenza vaccine prior to yellow fever vaccination. Vaccine 40:6, pages 961-966.
Crossref
Crossref
Amanda Izeli Portilho, Victor Araujo Correa, Emanuelle Baldo Gaspar & Elizabeth De Gaspari. 2022. Frontiers of COVID-19. Frontiers of COVID-19
539
559
.
Maria Luiza Benevides, Roger Walz & Jean Costa Nunes. (2021) Yellow Fever Vaccine as a Possible Trigger of Inflammatory Myopathy. JCR: Journal of Clinical Rheumatology 27:8S, pages S506-S508.
Crossref
Crossref
Clairissa A. Hansen & Alan D. T. Barrett. (2021) The Present and Future of Yellow Fever Vaccines. Pharmaceuticals 14:9, pages 891.
Crossref
Crossref
Amanda Araújo Serrão de Andrade, André E. R. Soares, Luiz Gonzaga Paula de Almeida, Luciane Prioli Ciapina, Cristiane Pinheiro Pestana, Carolina Lessa Aquino, Marco Alberto Medeiros & Ana Tereza Ribeiro de Vasconcelos. (2021) Testing the genomic stability of the Brazilian yellow fever vaccine strain using next-generation sequencing data. Interface Focus 11:4, pages 20200063.
Crossref
Crossref
Ivanildo P. SousaJr.Jr., Flavia B. dos Santos, Vanessa S. de Paula, Tuane C.R.G. Vieira, Helver G. Dias, Caroline A. Barros & Edson E. da Silva. (2021) Viral and Prion Infections Associated with Central Nervous System Syndromes in Brazil. Viruses 13:7, pages 1370.
Crossref
Crossref
Jordana Rodrigues Barbosa Fradico, Ana Carolina Campi-Azevedo, Vanessa Peruhype-Magalhães, Jordana Grazziela Alves Coelho-dos-Reis, Elaine Spezialli Faria, Betânia Paiva Drumond, Izabela Maurício de Rezende, Janaina Fonseca Almeida, Roberta Barros da Silva, Josiane Dias Gusmão, Eva Lídia Arcoverde Medeiros, Regina Coeli Magalhães Rodrigues, José Geraldo Leite Ribeiro, Maira Alves Pereira, Marcos Vinícius Ferreira Silva, Marília Lima Cruz Rocha, Talita Emile Ribeiro Adelino, Felipe Campos de Melo Iani, Glauco Carvalho Pereira, Eder Gatti Fernandes, Maria Auxiliadora-Martins, Valéria Valim, Matheus de Souza Gomes, Laurence Rodrigues Amaral, Alessandro Pecego Martins Romano, Daniel Garkauskas Ramos, Sandra Maria Deotti Carvalho, Francieli Fontana Sutile Tardetti Fantinato, Rodrigo Fabiano do Carmo Said, Andréa Teixeira-Carvalho & Olindo Assis Martins-Filho. (2021) CCL3, CCL5, IL-15, IL-1Ra and VEGF compose a reliable algorithm to discriminate classes of adverse events following 17DD-YF primary vaccination according to cause-specific definitions. Vaccine 39:31, pages 4359-4372.
Crossref
Crossref
Xianmiao Ye, Xinglong Liu, Tao Shu, Weiqi Deng, Min Liao, Yali Zheng, Xuehua Zheng, Xiaoyan Zhang, Ting Li, Wenxia Fan, Linbing Qu, Ling Chen, Feng Li & Liqiang Feng. (2021) A Live-Attenuated Zika Virus Vaccine with High Production Capacity Confers Effective Protection in Neonatal Mice. Journal of Virology 95:14.
Crossref
Crossref
Amanda Makha Bifani, Milly M. Choy, Hwee Cheng Tan & Eng Eong Ooi. (2021) Attenuated dengue viruses are genetically more diverse than their respective wild-type parents. npj Vaccines 6:1.
Crossref
Crossref
Anthony Uchenna Emeribe, Idris Nasir Abdullahi, Odunayo O. R. Ajagbe, Charles Egede Ugwu, Solomon Oloche Onoja, Sharafudeen Dahiru Abubakar, Chikodi Modesta Umeozuru, Olawale Sunday Animasaun, Pius Omoruyi Omosigho, Umar Mukhtar Danmusa, Mala Alhaji Baba Mallam, Maijiddah Saidu Aminu, Hadiza Yahaya & Silifat Oyewusi. (2021) Incidence, drivers and global health implications of the 2019/2020 yellow fever sporadic outbreaks in Sub-Saharan Africa. Pathogens and Disease 79:4.
Crossref
Crossref
Fabienne Piras-Douce, Franck Raynal, Alix Raquin, Yves Girerd-Chambaz, Sylviane Gautheron, Martha Erika Navarro Sanchez, Manuel Vangelisti & Nathalie Mantel. (2021) Next generation live-attenuated yellow fever vaccine candidate: Safety and immuno-efficacy in small animal models. Vaccine 39:13, pages 1846-1856.
Crossref
Crossref
Parikshit Tyagi, Milan Ganguly, Satyaprasad Manney, Kuntinath Wadkar, Nilesh Ingle, Sunil Gairola, Rajeev Dhere, Fusataka Koide & Sheila Grimes. (2021) Neurovirulence, Viscerotropism and Immunogenicity of Live Attenuated Yellow Fever 17D Vaccine Virus in Non-Human Primates. SSRN Electronic Journal.
Crossref
Crossref
Shengfeng Wan, Shengbo Cao, Xugang Wang, Yanfei Zhou, Weidong Yan, Xinbin Gu, Tzyy-Choou Wu & Xiaowu Pang. (2021) Generation and preliminary characterization of vertebrate-specific replication-defective Zika virus. Virology 552, pages 73-82.
Crossref
Crossref
Carleigh B. Krubiner, Ruth R. Faden, Ruth A. Karron, Margaret O. Little, Anne D. Lyerly, Jon S. Abramson, Richard H. Beigi, Alejandro R. Cravioto, Anna P. Durbin, Bruce G. Gellin, Swati B. Gupta, David C. Kaslow, Sonali Kochhar, Florencia Luna, Carla Saenz, Jeanne S. Sheffield & Paulina O. Tindana. (2021) Pregnant women & vaccines against emerging epidemic threats: Ethics guidance for preparedness, research, and response. Vaccine 39:1, pages 85-120.
Crossref
Crossref
Chadene Z. Tremaglio, John N. Barr & Rachel Fearns. 2021. Genome Stability. Genome Stability
23
38
.
Michael B. Yakass, David Franco & Osbourne Quaye. (2020) Yellow Fever Virus Down-Regulates mRNA Expression of SOCS1 in the Initial Phase of Infection in Human Cell Lines. Viruses 12:8, pages 802.
Crossref
Crossref
Himanshu Garg, Tugba Mehmetoglu-Gurbuz & Anjali Joshi. (2020) Virus Like Particles (VLP) as multivalent vaccine candidate against Chikungunya, Japanese Encephalitis, Yellow Fever and Zika Virus. Scientific Reports 10:1.
Crossref
Crossref
Emily H. DavisAlan D.T. Barrett. (2020) Structure–Function of the Yellow Fever Virus Envelope Protein: Analysis of Antibody Epitopes. Viral Immunology 33:1, pages 12-21.
Crossref
Crossref
James Sullivan & Stephen Brannan. 2020. Highly Infectious Diseases in Critical Care. Highly Infectious Diseases in Critical Care
119
138
.
Carleigh B. Krubiner & David A. Schwartz. (2019) Viral Hemorrhagic Fevers in Pregnant Women and the Vaccine Landscape: Comparisons Between Yellow Fever, Ebola, and Lassa Fever. Current Tropical Medicine Reports 6:4, pages 186-196.
Crossref
Crossref
Jaclyn A. Kaiser, Huanle Luo, Steven G. Widen, Thomas G. Wood, Claire Y.-H. Huang, Tian Wang & Alan D.T. Barrett. (2019) Genotypic and phenotypic characterization of West Nile virus NS5 methyltransferase mutants. Vaccine 37:48, pages 7155-7164.
Crossref
Crossref
Emily H. Davis, Andrew S. Beck, Ashley E. Strother, Jill K. Thompson, Steven G. Widen, Stephen Higgs, Thomas G. Wood & Alan D. T. Barrett. (2019) Attenuation of Live-Attenuated Yellow Fever 17D Vaccine Virus Is Localized to a High-Fidelity Replication Complex. mBio 10:5.
Crossref
Crossref
Robin D.V. Kleinert, Eduardo Montoya-Diaz, Tanvi Khera, Kathrin Welsch, Birthe Tegtmeyer, Sebastian Hoehl, Sandra Ciesek & Richard J.P. Brown. (2019) Yellow Fever: Integrating Current Knowledge with Technological Innovations to Identify Strategies for Controlling a Re-Emerging Virus. Viruses 11:10, pages 960.
Crossref
Crossref
Jaclyn A. Kaiser & Alan D.T. Barrett. (2019) Twenty Years of Progress Toward West Nile Virus Vaccine Development. Viruses 11:9, pages 823.
Crossref
Crossref
Rebecca M. Casey, Jennifer B. HarrisSteve Ahuka-MundekeMeredith G. DixonGabriel M. KizitoPierre M. NseleGrace UmutesiJaneen LavenOlga KosoyGilson PalukuAbdou S. GueyeTerri B. HydeRaimi EwetolaGuylain K.M. SheriaJean-Jacques Muyembe-TamfumJ. Erin Staples. (2019) Immunogenicity of Fractional-Dose Vaccine during a Yellow Fever Outbreak — Final Report. New England Journal of Medicine 381:5, pages 444-454.
Crossref
Crossref
Yasmin Mucunã Mustafá, Lana Monteiro Meuren, Sharton Vinícius Antunes Coelho & Luciana Barros de Arruda. (2019) Pathways Exploited by Flaviviruses to Counteract the Blood-Brain Barrier and Invade the Central Nervous System. Frontiers in Microbiology 10.
Crossref
Crossref
Derick Kimathi, Aitana Juan, Philip Bejon, Rebecca F. Grais & George M. Warimwe. (2019) Randomized, double-blinded, controlled non-inferiority trials evaluating the immunogenicity and safety of fractional doses of Yellow Fever vaccines in Kenya and Uganda. Wellcome Open Research 4, pages 182.
Crossref
Crossref
Jayme A. Souza-Neto, Jeffrey R. Powell & Mariangela Bonizzoni. (2019) Aedes aegypti vector competence studies: A review. Infection, Genetics and Evolution 67, pages 191-209.
Crossref
Crossref
Justin M Richner & Michael S Diamond. (2018) Zika virus vaccines: immune response, current status, and future challenges. Current Opinion in Immunology 53, pages 130-136.
Crossref
Crossref
Rui Song, Shengcan Guan, Shui Shan Lee, Zhihai Chen, Chen Chen, Lifen Han, Yanli Xu, Ang Li, Hui Zeng, Hanhui Ye & Fujie Zhang. (2018) Late or Lack of Vaccination Linked to Importation of Yellow Fever from Angola to China. Emerging Infectious Diseases 24:7, pages 1383-1386.
Crossref
Crossref
Xiao-Feng Li, Hao-Long Dong, Hong-Jiang Wang, Xing-Yao Huang, Ye-Feng Qiu, Xue Ji, Qing Ye, Chunfeng Li, Yang Liu, Yong-Qiang Deng, Tao Jiang, Gong Cheng, Fu-Chun Zhang, Andrew D. Davidson, Ya-Jun Song, Pei-Yong Shi & Cheng-Feng Qin. (2018) Development of a chimeric Zika vaccine using a licensed live-attenuated flavivirus vaccine as backbone. Nature Communications 9:1.
Crossref
Crossref
L. K. Metthew Lam, Alan M. Watson, Kate D. Ryman & William B. Klimstra. (2018) Gamma-interferon exerts a critical early restriction on replication and dissemination of yellow fever virus vaccine strain 17D-204. npj Vaccines 3:1.
Crossref
Crossref
Alan D.T. Barrett. (2017) Yellow fever live attenuated vaccine: A very successful live attenuated vaccine but still we have problems controlling the disease. Vaccine 35:44, pages 5951-5955.
Crossref
Crossref
Michael Holbrook. (2017) Historical Perspectives on Flavivirus Research. Viruses 9:5, pages 97.
Crossref
Crossref
Estefania Fernandez & Michael S Diamond. (2017) Vaccination strategies against Zika virus. Current Opinion in Virology 23, pages 59-67.
Crossref
Crossref
Norbert Pardi, Michael J. Hogan, Rebecca S. Pelc, Hiromi Muramatsu, Hanne Andersen, Christina R. DeMaso, Kimberly A. Dowd, Laura L. Sutherland, Richard M. Scearce, Robert Parks, Wendeline Wagner, Alex Granados, Jack Greenhouse, Michelle Walker, Elinor Willis, Jae-Sung Yu, Charles E. McGee, Gregory D. Sempowski, Barbara L. Mui, Ying K. Tam, Yan-Jang Huang, Dana Vanlandingham, Veronica M. Holmes, Harikrishnan Balachandran, Sujata Sahu, Michelle Lifton, Stephen Higgs, Scott E. Hensley, Thomas D. Madden, Michael J. Hope, Katalin Karikó, Sampa Santra, Barney S. Graham, Mark G. Lewis, Theodore C. Pierson, Barton F. Haynes & Drew Weissman. (2017) Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination. Nature 543:7644, pages 248-251.
Crossref
Crossref
Mia C. HikkeGorben P. Pijlman. (2017) Veterinary Replicon Vaccines. Annual Review of Animal Biosciences 5:1, pages 89-109.
Crossref
Crossref
Heverton Leandro Carneiro Dutra, Eric Pearce Caragata & Luciano Andrade Moreira. (2017) The re-emerging arboviral threat: Hidden enemies. BioEssays 39:2, pages 1600175.
Crossref
Crossref
Theodore C. Pierson & Barney S. Graham. (2016) Zika Virus: Immunity and Vaccine Development. Cell 167:3, pages 625-631.
Crossref
Crossref